I don't think there ever will be a BO from Merck. The reason is simple: Merck just cannot afford it. I strongly believe that the massive biologic manufacturing facilities by Merck and Amgen should have something to do with DCVax-L.
Take a look at the manufacturing facilities at Merck West Point campus. They are all related to vaccine. If you check the job postings in the last six months, you may ask yourself: what are the other possible vaccines that Merck is going to manufacture 247 once they are in operation?
Market Data 
Markets 
AI
